{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:51:11Z","timestamp":1791474671328,"version":"4.3.4"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:00:00Z","timestamp":1593734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:00:00Z","timestamp":1593734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1038\/s41401-020-0459-6","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T10:02:47Z","timestamp":1593770567000},"page":"536-549","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["GJA1-20k attenuates Ang II-induced pathological cardiac hypertrophy by regulating gap junction formation and mitochondrial function"],"prefix":"10.1038","volume":"42","author":[{"given":"Yi-le","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-hua","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning-ze","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-yi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,3]]},"reference":[{"key":"459_CR1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","volume":"65","author":"N Frey","year":"2003","unstructured":"Frey N, Olson EN. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol. 2003;65:45\u201379.","journal-title":"Annu Rev Physiol"},{"key":"459_CR2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrm1983","volume":"7","author":"J Heineke","year":"2006","unstructured":"Heineke J, Molkentin JD. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol. 2006;7:589\u2013600.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"459_CR3","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0195-668X(02)00829-1","volume":"24","author":"DJ Lips","year":"2003","unstructured":"Lips DJ, dewindt LJ, Van Kraaij DJ, Doevendans PA. Molecular determinants of myocardial hypertrophy and failure: alternative pathways for beneficial and maladaptive hypertrophy. Eur Heart J. 2003;24:883\u201396.","journal-title":"Eur Heart J"},{"key":"459_CR4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1471-4914(03)00114-X","volume":"9","author":"O Ritter","year":"2003","unstructured":"Ritter O, Neyses L. The molecular basis of myocardial hypertrophy and heart failure. Trends Mol Med. 2003;9:313\u201321.","journal-title":"Trends Mol Med"},{"key":"459_CR5","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1096\/fasebj.5.15.1835945","volume":"5","author":"KR Chien","year":"1991","unstructured":"Chien KR, Knowlton KU. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J 1991;5:3037\u201346.","journal-title":"FASEB J"},{"key":"459_CR6","first-page":"12300","volume":"43","author":"HarrisAL Bruzzone","year":"2009","unstructured":"Bruzzone HarrisAL, Locke D. Connexins: a guide. Mol Biotechnol 2009;43:12300\u20139.","journal-title":"Mol Biotechnol"},{"key":"459_CR7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00232-007-9031-2","volume":"218","author":"JE Saffitz","year":"2007","unstructured":"Saffitz JE, Hames KY, Kanno S. Remodeling of gap junctions in ischemic and nonischemic forms of heart disease. J Membr Biol. 2007;218:65\u201371.","journal-title":"J Membr Biol"},{"key":"459_CR8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/cvr\/cvn133","volume":"80","author":"NJ Severs","year":"2008","unstructured":"Severs NJ, Bruce AF, Dupont E, Rothery S. Remodelling of gap junctions and connexin expression in diseased myocardium. Cardiovasc Res 2008;80:9\u201319.","journal-title":"Cardiovasc Res"},{"key":"459_CR9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1042\/cs0900447","volume":"90","author":"NS Peters","year":"1996","unstructured":"Peters NS. New insights into myocardial arrhythmogenesis: distribution of gap-junctional coupling in normal, ischaemic and hypertrophied hearts. Clin Sci. 1996;90:447\u201352.","journal-title":"Clin Sci"},{"key":"459_CR10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1023\/A:1021154115673","volume":"242","author":"S Kostin","year":"2003","unstructured":"Kostin S, Rieger M, Dammer S, Hein S, Richter M, Kl\u00f6vekorn WP, et al. Gap junction remodeling and altered connexin43 expression in the failing human heart. Mol Cell Biochem. 2003;242:135\u201344.","journal-title":"Mol Cell Biochem"},{"key":"459_CR11","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1046\/j.1540-8167.2002.00865.x","volume":"13","author":"H Kitamura","year":"2002","unstructured":"Kitamura H, Ohnishi Y, Yoshida A, Okajima K, Azumi H, Ishida A, et al. Heterogeneous loss of connexin43 protein in nonischemic dilated cardiomyopathy with ventricular tachycardia. J Cardiovasc Electrophysiol. 2002;13:865\u201370.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"459_CR12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1006\/jmcc.2000.1308","volume":"33","author":"E Dupont","year":"2001","unstructured":"Dupont E, Matsushita T, Kaba RA, Vozzi C, Coppen SR, Khan N, et al. Altered connexin expression in human congestive heart failure. J Mol Cell Cardiol. 2001;33:359\u201371.","journal-title":"J Mol Cell Cardiol"},{"key":"459_CR13","first-page":"240","volume":"6","author":"A Angeliki","year":"2014","unstructured":"Angeliki A, Sudhir K, Eva P, Anne KA, Edward A, Zhenzhen L, et al. Identification of a new modulator of the intercalated disc in a zebrafish model of arrhythmogenic cardiomyopathy. Sci Transl Med. 2014;6:240\u201374.","journal-title":"Sci Transl Med"},{"key":"459_CR14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00232-012-9448-0","volume":"245","author":"BF Remo","year":"2012","unstructured":"Remo BF, Giovannone S, Fishman GI. Connexin43 cardiac gap junction remodeling: lessons from genetically engineered murine models. J Membr Biol. 2012;245:275\u201381.","journal-title":"J Membr Biol"},{"key":"459_CR15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1540-8159.1997.tb06199.x","volume":"20","author":"MS Spach","year":"1997","unstructured":"Spach MS, Boineau JP. Microfibrosis produces electrical load variations due to loss of side-to-side cell connections: a major mechanism of structural heart disease arrhythmias. Pacing Clin Electrophysiol. 1997;20:397\u2013413.","journal-title":"Pacing Clin Electrophysiol"},{"key":"459_CR16","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.ijcard.2012.09.082","volume":"167","author":"LY Zhou","year":"2013","unstructured":"Zhou LY, Liu JP, Wang K, Gao J, Ding SL, Jiao JQ, et al. Mitochondrial function in cardiac hypertrophy. Int J Cardiol. 2013;167:1118\u201325.","journal-title":"Int J Cardiol"},{"key":"459_CR17","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/01.RES.45.6.697","volume":"45","author":"J Wikman-Coffelt","year":"1979","unstructured":"Wikman-Coffelt J, Parmley WW, Mason DT. The cardiac hypertrophy process. Analyses of factors determining pathological vs. physiological development. Circ Res. 1979;45:697\u2013707.","journal-title":"Circ Res"},{"key":"459_CR18","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.bbamem.2011.06.011","volume":"1818","author":"M Vinken","year":"2012","unstructured":"Vinken M, Decrock E, Leybaert L, Bultynck G, Himpens B, Vanhaecke T, et al. Non-channel functions of connexins in cell growth and cell death. Biochim Biophys Acta. 2012;1818:2002\u20138.","journal-title":"Biochim Biophys Acta"},{"key":"459_CR19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.pbiomolbio.2007.03.009","volume":"94","author":"E Kardami","year":"2007","unstructured":"Kardami E, Dang X, Iacobas DA, Nickel BE, Jeyaraman M, Srisakuldee W, et al. The role of connexins in controlling cell growth and gene expression. Prog Biophys Mol Biol. 2007;94:245\u201364.","journal-title":"Prog Biophys Mol Biol"},{"key":"459_CR20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12860-016-0094-8","volume":"17","author":"JX Jiang","year":"2016","unstructured":"Jiang JX, Penuela S. Connexin and pannexin channels in cancer. BMC Mol Cell Biol. 2016;17:12\u201326.","journal-title":"BMC Mol Cell Biol"},{"key":"459_CR21","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrc.2016.105","volume":"16","author":"T Aasen","year":"2016","unstructured":"Aasen T, Mesnil M, Naus CC, Lampe PD, Laird DW. Gap junctions and cancer: communicating for 50 years. Nat Rev Cancer. 2016;16:775\u201388.","journal-title":"Nat Rev Cancer"},{"key":"459_CR22","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.celrep.2013.10.009","volume":"5","author":"JW Smyth","year":"2013","unstructured":"Smyth JW, Shaw RM. Autoregulation of connexin43 gap junction formation by internally translated isoforms. Cell Rep. 2013;5:611\u20138.","journal-title":"Cell Rep"},{"key":"459_CR23","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3389\/fphys.2017.00905","volume":"8","author":"Y Fu","year":"2017","unstructured":"Fu Y, Zhang SS, Xiao S, Basheer A, Baum R, Epifantseva I, et al. Cx43 isoform GJA11-20k promotes microtubule dependent mitochondrial transport. Front Physiol 2017;8:905\u201317.","journal-title":"Front Physiol"},{"key":"459_CR24","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1172\/jci.insight.121900","volume":"3","author":"WA Basheer","year":"2018","unstructured":"Basheer WA, Fu Y, Shimura D, Xiao S, Agvanian S, Hernandez DM, et al. Stress response protein GJA1-20k promotes mitochondrial biogenesis, metabolic quiescence, and cardioprotection against ischemia\/reperfusion injury. JCI Insight 2018;3:378\u201390.","journal-title":"JCI Insight"},{"key":"459_CR25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijcard.2018.05.133","volume":"270","author":"D Yang","year":"2018","unstructured":"Yang D, Xi J, Xing Y, Tang X, Dai X, Li K, et al. A new method for neonatal rat ventricular myocyte purification using superparamagnetic iron oxide particles. Int J Cardiol. 2018;270:293\u2013301.","journal-title":"Int J Cardiol"},{"key":"459_CR26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.intimp.2016.03.041","volume":"35","author":"Y Wang","year":"2016","unstructured":"Wang Y, Wang F, Yang D. Berberine in combination with yohimbine attenuates sepsis-induced neutrophil tissue infiltration and multiorgan dysfunction partly via IL-10-mediated inhibition of CCR2 expression in neutrophils. Int Immunopharmacol. 2016;35:217\u201325.","journal-title":"Int Immunopharmacol"},{"key":"459_CR27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13046-019-1142-y","volume":"38","author":"Y Xiang","year":"2019","unstructured":"Xiang Y, Wang Q, Guo Y, Ge H, Fu Y, Wang X, et al. Cx32 exerts anti-apoptotic and pro-tumor effects via the epidermal growth factor receptor pathway in hepatocellular carcinoma. J Exp Clin Cancer Res. 2019;38:145\u201360.","journal-title":"J Exp Clin Cancer Res"},{"key":"459_CR28","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1161\/CIRCULATIONAHA.108.823799","volume":"119","author":"TA Doser","year":"2009","unstructured":"Doser TA, Turdi S, Thomas DP, Epstein PN, Li SY, Ren J. Transgenic overexpression of aldehyde dehydrogenase-2 rescues chronic alcohol intake-induced myocardial hypertrophy and contractile dysfunction. Circulation 2009;119:1941\u20139.","journal-title":"Circulation"},{"key":"459_CR29","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000489799","volume":"47","author":"Z Shi","year":"2018","unstructured":"Shi Z, Wei Z, Li J, Yuan S, Pan B, Cao F, et al. Identification and verification of candidate genes regulating neural stem cells behavior under hypoxia. Cell Physiol Biochem. 2018;47:212\u201322.","journal-title":"Cell Physiol Biochem"},{"key":"459_CR30","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"459_CR31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0165-6147(03)00079-8","volume":"24","author":"BH Shah","year":"2003","unstructured":"Shah BH, Catt KJ. A central role of EGF receptor transactivation in angiotensin II-induced cardiac hypertrophy. Trends Pharmacol Sci. 2003;24:239\u201344.","journal-title":"Trends Pharmacol Sci."},{"key":"459_CR32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1478-811X-12-31","volume":"12","author":"C Salat-Canela","year":"2014","unstructured":"Salat-Canela C, Ses\u00e9 M, Peula C, Cajal SRY, Aasen T. Internal translation of the connexin 43 transcript. Cell Commun Signal. 2014;12:31\u201344.","journal-title":"Cell Commun Signal"},{"key":"459_CR33","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/dvdy.20426","volume":"233","author":"B Chatterjee","year":"2005","unstructured":"Chatterjee B, Chin AJ, Valdimarsson G, Finis C, Sonntag JM, Choi BY, et al. Developmental regulation and expression of the zebrafish connexin43 gene. Dev Dynam. 2005;233:890\u2013906.","journal-title":"Dev Dynam"},{"key":"459_CR34","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/CIRCRESAHA.117.311955","volume":"121","author":"WA Basheer","year":"2017","unstructured":"Basheer WA, Xiao S, Epifantseva I, Fu Y, Kleber AG, Hong T, et al. GIA1-20k arranges actin to guide Cx43 delivery to cardiac intercalated discs. Circ Res 2017;121:1069\u201380.","journal-title":"Circ Res"},{"key":"459_CR35","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1091\/mbc.E17-06-0406","volume":"29","author":"CC James","year":"2018","unstructured":"James CC, Zeitz MJ, Calhoun PJ, Lamouille S, Smyth JW. Altered translation initiation of GJA1 limits gap junction formation during epithelial\u2013mesenchymal transition. Mol Biol Cell. 2018;29:797\u2013808.","journal-title":"Mol Biol Cell"},{"key":"459_CR36","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1006\/jmcc.2002.2076","volume":"34","author":"GW Booz","year":"2002","unstructured":"Booz GW, Day JN, Baker KM. Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: role in cardiac hypertrophy, ischemia\/reperfusion dysfunction, and heart failure. J Mol Cell Cardiol. 2002;34:1443\u201353.","journal-title":"J Mol Cell Cardiol"},{"key":"459_CR37","doi-asserted-by":"crossref","first-page":"5590","DOI":"10.1073\/pnas.95.10.5590","volume":"95","author":"E Mascareno","year":"1998","unstructured":"Mascareno E, Dhar M, Siddiqui MA. Signal transduction and activator of transcription (STAT) protein-dependent activation of angiotensinogen promoter: a cellular signal for hypertrophy in cardiac muscle. Proc Natl Acad Sci USA. 1998;95:5590\u20134.","journal-title":"Proc Natl Acad Sci USA."},{"key":"459_CR38","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1007157126806","volume":"212","author":"E Mascareno","year":"2000","unstructured":"Mascareno E, Siddiqui MA. The role of Jak\/STAT signaling in heart tissue renin\u2013angiotensin system. Mol Cell Biochem. 2000;212:171\u20135.","journal-title":"Mol Cell Biochem"},{"key":"459_CR39","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.phrs.2009.11.012","volume":"61","author":"A Rohini","year":"2010","unstructured":"Rohini A, Agrawal N, Koyani CN, Singh R. Molecular targets and regulators of cardiac hypertrophy. Pharmacol Res. 2010;61:269\u201380.","journal-title":"Pharmacol Res."},{"key":"459_CR40","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1073\/pnas.97.1.315","volume":"97","author":"K Kunisada","year":"2000","unstructured":"Kunisada K, Negoro S, Tone E, Funamoto M, Osugi T, Yamada S, et al. Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy. Proc Natl Acad Sci USA. 2000;97:315\u20139.","journal-title":"Proc Natl Acad Sci USA."},{"key":"459_CR41","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nm1199","volume":"11","author":"M Harada","year":"2005","unstructured":"Harada M, Qin Y, Takano H, Minamino T, Zou Y, Toko H, et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med 2005;11:305\u201311.","journal-title":"Nat Med"},{"key":"459_CR42","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1016\/j.celrep.2019.04.114","volume":"27","author":"MJ Zeitz","year":"2019","unstructured":"Zeitz MJ, Calhoun PJ, James CC, Taetzsch T, George KK, Robel S, et al. Dynamic UTR usage regulates alternative translation to modulate gap junction formation during stress and aging. Cell Rep. 2019;27:2737\u201347.","journal-title":"Cell Rep."},{"key":"459_CR43","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.tips.2010.12.001","volume":"32","author":"MJ Cutler","year":"2011","unstructured":"Cutler MJ, Jeyaraj D, Rosenbaum DS. Cardiac electrical remodeling in health and disease. Trends Pharmacol Sci. 2011;32:174\u201380.","journal-title":"Trends Pharmacol Sci."},{"key":"459_CR44","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1152\/ajpheart.00346.2004","volume":"287","author":"S Pozlzing","year":"2004","unstructured":"Pozlzing S, Rosenbaum DS. Altered Connexin43 expression produces arrhythmia substrate in heart failure. Am J Physiol Heart Circ Physiol. 2004;287:1762\u201370.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"459_CR45","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1152\/ajpheart.00079.2007","volume":"293","author":"FG Akar","year":"2007","unstructured":"Akar FG, Nass RD, Hahn S, Tomaselli GF. Dynamic changes in conduction velocity and gap junction properties during development of pacing-induced heart failure. Am J Physiol Heart Circ Physiol. 2007;293:1223\u201330.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"459_CR46","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/01.RES.0000144125.61927.1c","volume":"95","author":"FG Akar","year":"2004","unstructured":"Akar FG, Spragg DD, Tunin RS, Kass DA, Tomaselli GF. Mechanisms underlying conduction slowing and arrhythmogenesis in nonischemic dilated cardiomyopathy. Circ Res. 2004;95:717\u201325.","journal-title":"Circ Res."},{"key":"459_CR47","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1161\/01.RES.0000148664.33695.2a","volume":"95","author":"SB Danik","year":"2004","unstructured":"Danik SB, Liu F, Zhang J. Modulation of cardiac gap junction expression and arrhythmic susceptibility. Circ Res. 2004;95:1035\u201341.","journal-title":"Circ Res."},{"key":"459_CR48","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/01.RES.88.3.333","volume":"88","author":"DE Gutstein","year":"2001","unstructured":"Gutstein DE, Morley GE, Tamaddon H, Vaidya D, Schneider MD, Chen J, et al. Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ Res. 2001;88:333\u20139.","journal-title":"Circ Res."},{"key":"459_CR49","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1161\/hc3601.093990","volume":"104","author":"DE Gutstein","year":"2001","unstructured":"Gutstein DE, Morley GE, Vaidya D, Fishman GI. Heterogeneous expression of gap junction channels in the heart leads to conduction defects and ventricular dysfunction. Circulation. 2001;104:1194\u20139.","journal-title":"Circulation"},{"key":"459_CR50","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1124\/pr.115.012062","volume":"69","author":"L Leybaert","year":"2017","unstructured":"Leybaert L, Lampe PD, Dhein S, Kwak BR, Ferdinandy P, Beyer EC, et al. Connexins in cardiovascular and neurovascular health and disease: pharmacological implications. Pharmacol Rev. 2017;69:396\u2013478.","journal-title":"Pharmacol Rev."},{"key":"459_CR51","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1161\/CIRCRESAHA.108.182147","volume":"106","author":"GG Hesketh","year":"2010","unstructured":"Hesketh GG, Shah MH, Halperin VL, Cooke CA, Akar FG, et al. Ultrastructure and regulation of lateralized connexin43 in the failing heart. Circ Res. 2010;106:1153\u201363.","journal-title":"Circ Res."},{"key":"459_CR52","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/BF00241093","volume":"350","author":"S Dhein","year":"1994","unstructured":"Dhein S, Manicone N, M\u00fcller A, Gerwin R, Ziskoven U, Irankhahi A, et al. A new synthetic antiarrhythmic peptide reduces dispersion of epicardial activation recovery interval and diminishes alterations of epicardial activation patterns induced by regional ischemia. Naunyn Schmiedebergs Arch Pharmacol. 1994;350:174\u201384.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"key":"459_CR53","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/cvr\/cvn100","volume":"79","author":"X Lin","year":"2008","unstructured":"Lin X, Zemlin C, Hennan JK, Petersen JS, Veenstra RD. Enhancement of ventricular gap-junction coupling by rotigaptide. Cardiovasc Res. 2008;79:416\u201326.","journal-title":"Cardiovasc Res"},{"key":"459_CR54","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/sj.bjp.0706631","volume":"147","author":"TC Clarke","year":"2006","unstructured":"Clarke TC, Thomas D, Petersen JS, Evans WH, Martin PE. The antiarrhythmic peptide rotigaptide (ZP123) increases gap junction intercellular communication in cardiac myocytes and HeLa cells expressing connexin43. Br J Pharmacol. 2006;147:486\u201395.","journal-title":"Br J Pharmacol."},{"key":"459_CR55","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1210\/en.2004-1414","volume":"146","author":"NR Jorgensen","year":"2005","unstructured":"Jorgensen NR, Teilmann SC, Henriksen Z, Meier E, Hansen SS, Jensen JE, et al. The antiarrhythmic peptide analog rotigaptide (ZP123) stimulates gap junction intercellular communication in human osteoblasts and prevents decrease in femoral trabecular bone strength in ovariectomized rats. Endocrinology. 2005;146:4745\u201354.","journal-title":"Endocrinology"},{"key":"459_CR56","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1124\/jpet.108.150102","volume":"329","author":"EI Rossman","year":"2009","unstructured":"Rossman EI, Liu K, Morgan GA, Swillo RE, Krueger JA, Gardell SJ, et al. The gap junction modifier, improves conduction and reduces atrial fibrillation\/flutter in the canine sterile pericarditis model. J Pharmacol Exp Ther. 2009;329:1127\u201333.","journal-title":"J Pharmacol Exp Ther."},{"key":"459_CR57","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/CIRCEP.108.790212","volume":"2","author":"G Laurent","year":"2009","unstructured":"Laurent G, Leong-Poi H, Mangat I, Moe GW, Hu X, So PP, et al. Effects of chronic gap junction conduction-enhancing antiarrhythmic peptide GAP-134 administration on experimental atrial fibrillation in dogs. Circ Arrhythmia Electrophysiol. 2009;2:171\u20138.","journal-title":"Circ Arrhythmia Electrophysiol."},{"key":"459_CR58","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1111\/bph.13804","volume":"174","author":"K Boengler","year":"2017","unstructured":"Boengler K, Bulic M, Schreckenberg R, Schl\u00fcter KD, Schulz R. The gap junction modifier ZP1609 decreases cardiomyocyte hypercontracture following ischaemia\/reperfusion independent from mitochondrial connexin43. Br J Pharmacol. 2017;174:2060\u201373.","journal-title":"Br J Pharmacol."},{"key":"459_CR59","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00210-013-0840-9","volume":"386","author":"A Skyschally","year":"2013","unstructured":"Skyschally A, Walter B, Schultz Hansen R, Heusch G. The antiarrhythmic dipeptide ZP1609 (danegaptide) when given at reperfusion reduces myocardial infarct size in pigs. Naunyn Schmiedebergs Arch Pharmacol. 2013;386:383\u201391.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41401-020-0459-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-020-0459-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-020-0459-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:03:42Z","timestamp":1684616622000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-0459-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,3]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["459"],"URL":"https:\/\/doi.org\/10.1038\/s41401-020-0459-6","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,3]]},"assertion":[{"value":"2 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}